Table 3 Adverse events during first-line Helicobacter pylori eradication therapy
From: Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
TT | SET | P value | |
|---|---|---|---|
N = 872 (74.3%) | N = 302 (25.7%) | ||
Total | 33 (3.8) | 10 (3.3) | 0.706 |
Diarrhea | 11 (1.3) | 5 (1.7) | 0.574 |
Nausea or vomiting | 9 (1.0) | 3 (1.0) | 0.999 |
Abdominal pain | 8 (0.9) | 0 (0) | 0.122 |
Skin rash | 1 (0.1) | 1 (0.3) | 0.448 |
Metallic taste | 1 (0.1) | 0 (0) | 0.999 |
Othersa | 5 (0.6) | 2 (0.7) | 0.999 |